Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma.

van Rensen, E L; Stirling, R G; Scheerens, J; Staples, K; Sterk, P J; Barnes, P J; Chung, K F

van Rensen, E L; Stirling, R G; Scheerens, J; Staples, K; Sterk, P J; Barnes, P J; Chung, K F.

Affiliation

van Rensen EL; Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London SW3 6LY, UK.

Thorax ; 56(12): 935-40, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11713356

Subject(s)

Asthma/drug therapy; Interleukin-5/pharmacology; Administration, Inhalation; Adult; Analysis of Variance; Asthma/metabolism; Bronchial Provocation Tests; Cell Count; Chemokine CCL11; Chemokines, CC/blood; Cross-Over Studies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Forced Expiratory Volume; Humans; Infusions, Intravenous; Interleukin-5/administration & dosage; Interleukin-5/analysis; Male; Pulmonary Eosinophilia/chemically induced; Sputum/cytology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Interleukin-5 Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Thorax Year: 2001 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google